Guest guest Posted July 30, 2008 Report Share Posted July 30, 2008 How health challenges can change you spiritually. Seeing through someone else's eyes. Interesting article. http://cms.carepages.com/CarePages/en/Newsletters/7_08/spirituality_helps.html?i\ pc=nlaug_spotlight_1 www.familydoctor.org offers information on how spirituality is related to your health.http://familydoctor.org/online/famdocen/home/articles/650.html (Reuters) - Novartis cancer drug Glivec failed to meet its main target in a late-stage study of patients with chronic myeloid leukaemia (CML), according to the Swiss drugmaker. http://www.reuters.com/article/rbssPharmaceuticals%20-%20Diversified/idUSL135144\ 3720080613 Novartis Clinical trial search http://www.novartisclinicaltrials.com/webapp/etrials/DiseaseID30/Chronic-Myeloge\ nous-Leukemia-(CML)-clinical-trials.go?pl_id=bmretk110000 & gclid=CKCn0rmw6JQCFRee\ nAodIim-SQ OHSU Cancer Institute Researchers Find New Drug Candidate Knocks Out Resistant Form Of Chronic Myeloid Leukemia. The combination of SGX393 with either Sprycel or Tasigna completely suppressed resistant growth. http://www.ohsu.edu/ohsuedu/newspub/releases/121007drug.cfm AP24534 has been shown to selectively block a series of well-validated cancer targets known to play critical roles in the pathogenesis of several hematological cancers and solid tumors. Especially in patients with the drug-resistant forms of CML, where the genetic basis for the disease can be readily measured in individual patients, we expect this trial to provide insights into the potential therapeutic effects of AP24534 early in its clinical development. " https://www.sharebuilder.com/sharebuilder/Research/MarketUpdate/StockNews.aspx?G\ UID={C080AB54-2535-4A1D-A868-69BA2FFAA4D8} & Symbol=ARIA Blessings, Lottie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.